A popular class of therapies for treating diabetes and obesity may also have the potential to treat alcohol and drug addiction, according to a new paper published in the Journal of the Endocrine Society. The therapies, known as Glucagon-Like Peptide-1 Receptor Agonists (GLP-1RAs), present an encouraging approach to treating alcohol and other substance use disorders. “Early...
A new study in The Journal of Clinical Endocrinology & Metabolism has revealed a concerning paradox in the management of osteoporosis in the United States. While the use of drug therapies for the bone-weakening disease has increased over the last decade, a significant and persistent trend of underdiagnosis means millions of high-risk patients are missing...
A recent clinical trial reveals encouraging news for a Cushing’s disease treatment A poster from ENDO 2025 showed that osilodrostat provides sustained clinical benefits in Cushing’s patients who experienced positive outcomes by the end of the treatment period. Richard Auchus, MD, PhD, discusses how the data reinforces the drug’s use, which was well-tolerated for extended...
With skill, hard work, and a bit of luck, almost anyone can achieve their career goals. But with the backing of a renowned global organization — filled with the best minds in the field and offering world-class educational and development programs — you can soar to the highest levels of professional success. Of course, I’m...
Divya Sistla, MD, FACP, a steering committee member of the Endocrine Society’s Early-Career Special Interest Group (SIG), discusses how the University of Pittsburgh Medical Center uses a multidisciplinary approach to successfully improve osteoporosis treatment via a fracture liaison service. In the United States, approximately 2 million new cases of osteoporotic fractures are diagnosed annually. This...
As of this posting, the U.S. House of Representatives and Senate are not close to agreement on an appropriations bill that would fund the Department of Health and Human Services, the National Institutes of Health (NIH), and other federal health agencies for fiscal year 2026, which begins on October 1. Consequently, a partial federal government shutdown...
An Endocrine News roundup of the week’s pharmaceutical news, breakthroughs, and general information. * Study Shows BDI Screening of Existing Patient CT Scans for Undetected Osteoporosis Also Finds Undetected Cardiovascular Disease Risk Many studies have shown the inverse relationship between bone mineral density (BMD) – the gold standard measure for osteopenia/osteoporosis – and coronary calcium...
Revolutionary artificial intelligence applications transform endocrine disease detection and management Attendees at ENDO 2025 in San Francisco were all buzzing about the Elangovan family of Houston, Texas. That’s because high school-aged siblings, Ramya and Kavin, were presenting their research into how artificial intelligence (AI) could change the way certain endocrine disorders were diagnosed and treated....
With skill, hard work, and a bit of luck, almost anyone can achieve their career goals. But with the backing of a renowned global organization — filled with the best minds in the field and offering world-class educational and development programs — you can soar to the highest levels of professional success. Of course, I’m...
